SHI
SV Health Investors Portfolio holdings
AUM $32.3M
1-Year Return
20.15%
This Quarter Return
-39.48%
1 Year Return
-20.15%
3 Year Return
+90.94%
5 Year Return
+318.05%
10 Year Return
–
AUM
$162M
AUM Growth
-$179M
(-52%)
Cap. Flow
-$10M
Cap. Flow
% of AUM
-6.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
4
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$9.01M |
| 2 |
KalVista Pharmaceuticals
KALV
|
+$618K |
| 3 |
Ocular Therapeutix
OCUL
|
+$377K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
KalVista Pharmaceuticals
KALV
$688M
| $50.3M | 30.98% |
2,548,202
-31,288
| -1% | -$618K |
|
|
TECX
2
Tectonic Therapeutic, Inc. Common Stock
TECX
$310M
| $45.6M | 28.05% |
228,002
| – | – |
|
|
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $27M | 16.63% |
1,287,227
-429,076
| -25% | -$9.01M |
|
4
Sutro Biopharma
STRO
$75.3M
| $16.5M | 10.13% |
1,824,542
| – | – |
|
|
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
| $15M | 9.23% |
510,141
| – | – |
|
6
X4 Pharmaceuticals
XFOR
$67.1M
| $4.34M | 2.67% |
10,383
| – | – |
|
|
7
Ocular Therapeutix
OCUL
$2.18B
| $2.5M | 1.54% |
628,236
-94,700
| -13% | -$377K |
|
8
Astria Therapeutics
ATXS
$416M
| $1.25M | 0.77% |
47,628
| – | – |
|
|
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
| $0 | ﹤0.01% |
1,072
-148,992
| -99% | – |
|